FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077417004> ?p ?o ?g. }

• W2077417004 endingPage "209" @default.
• W2077417004 startingPage "203" @default.
• W2077417004 abstract "Abstract: Objectives : To evaluate therapeutic results and prognostic factors from a series of 44 patients affected by de novo acute myeloid leukemia with multilineage dysplasia (MD-AML), treated with the combination of fludarabine, cytarabine and G-CSF (FLAG). Methods : Forty-four patients with de novo MD-AML were treated with the FLAG regimen. The median age was 61 yr (range 31–75 yr). Induction therapy consisted of the FLAG regimen; consolidation included idarubicin plus cytarabine. Patients with a compatible donor and aged less than 55 yr were programmed to receive allogeneic bone marrow transplantation (BMT), while in those without a donor and aged less than 65 yr autologous transplantation with peripheral blood stem cells mobilized by a consolidation regimen plus G-CSF was planned. Bone marrow harvest was performed in poor mobilizers. Results : Complete remission (CR) was achieved in 28 out of 44 patients (64%). Death in induction occurred in four patients (9%), while 12 patients (27%) were resistant to FLAG. Toxicity of consolidation was negligible. Most patients aged less than 60 yr and achieving CR were eligible for transplantation procedures, the main reason of exclusion being early relapse. Median overall survival and disease free survival were 16 and 22 months, respectively. Unfavorable cytogenetics was the only parameter significantly related to inferior clinical outcome following multivariate analysis. Conclusion : Multilineage dysplasia per se is not an adverse prognostic factor in AML patients treated with the FLAG regimen. Favorable results are obtained in patients with intermediate karyotype, while in those with adverse cytogenetics new approaches are clearly needed. The toxicity of the regimen is also acceptable in the elderly, and following induction/consolidation, most patients may be submitted to transplantation procedures." @default.
• W2077417004 created "2016-06-24" @default.
• W2077417004 creator A5000684645 @default.
• W2077417004 creator A5025734160 @default.
• W2077417004 creator A5025826387 @default.
• W2077417004 creator A5031981505 @default.
• W2077417004 creator A5042609656 @default.
• W2077417004 creator A5045607668 @default.
• W2077417004 creator A5048679174 @default.
• W2077417004 creator A5056302915 @default.
• W2077417004 creator A5060752899 @default.
• W2077417004 creator A5071784692 @default.
• W2077417004 creator A5072941996 @default.
• W2077417004 date "2002-04-01" @default.
• W2077417004 modified "2023-09-27" @default.
• W2077417004 title "De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG)" @default.
• W2077417004 cites W1534965621 @default.
• W2077417004 cites W1814791463 @default.
• W2077417004 cites W1819781110 @default.
• W2077417004 cites W1857665725 @default.
• W2077417004 cites W1970187492 @default.
• W2077417004 cites W1974804829 @default.
• W2077417004 cites W2019903968 @default.
• W2077417004 cites W2020851999 @default.
• W2077417004 cites W2032566132 @default.
• W2077417004 cites W2044311624 @default.
• W2077417004 cites W2048591988 @default.
• W2077417004 cites W2060582225 @default.
• W2077417004 cites W2061876001 @default.
• W2077417004 cites W2078918374 @default.
• W2077417004 cites W2080555719 @default.
• W2077417004 cites W2086797447 @default.
• W2077417004 cites W2094655273 @default.
• W2077417004 cites W2117291755 @default.
• W2077417004 cites W2144749137 @default.
• W2077417004 cites W2150113701 @default.
• W2077417004 cites W2154932346 @default.
• W2077417004 cites W2155540898 @default.
• W2077417004 cites W2162700652 @default.
• W2077417004 cites W2312509177 @default.
• W2077417004 cites W2331452086 @default.
• W2077417004 cites W4233891734 @default.
• W2077417004 cites W4293241248 @default.
• W2077417004 doi "https://doi.org/10.1034/j.1600-0609.2002.01651.x" @default.
• W2077417004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12071935" @default.
• W2077417004 hasPublicationYear "2002" @default.
• W2077417004 type Work @default.
• W2077417004 sameAs 2077417004 @default.
• W2077417004 citedByCount "37" @default.
• W2077417004 countsByYear W20774170042012 @default.
• W2077417004 countsByYear W20774170042013 @default.
• W2077417004 countsByYear W20774170042014 @default.
• W2077417004 countsByYear W20774170042015 @default.
• W2077417004 countsByYear W20774170042016 @default.
• W2077417004 countsByYear W20774170042017 @default.
• W2077417004 countsByYear W20774170042022 @default.
• W2077417004 crossrefType "journal-article" @default.
• W2077417004 hasAuthorship W2077417004A5000684645 @default.
• W2077417004 hasAuthorship W2077417004A5025734160 @default.
• W2077417004 hasAuthorship W2077417004A5025826387 @default.
• W2077417004 hasAuthorship W2077417004A5031981505 @default.
• W2077417004 hasAuthorship W2077417004A5042609656 @default.
• W2077417004 hasAuthorship W2077417004A5045607668 @default.
• W2077417004 hasAuthorship W2077417004A5048679174 @default.
• W2077417004 hasAuthorship W2077417004A5056302915 @default.
• W2077417004 hasAuthorship W2077417004A5060752899 @default.
• W2077417004 hasAuthorship W2077417004A5071784692 @default.
• W2077417004 hasAuthorship W2077417004A5072941996 @default.
• W2077417004 hasConcept C126322002 @default.
• W2077417004 hasConcept C136119220 @default.
• W2077417004 hasConcept C141071460 @default.
• W2077417004 hasConcept C143998085 @default.
• W2077417004 hasConcept C202444582 @default.
• W2077417004 hasConcept C2776694085 @default.
• W2077417004 hasConcept C2776730729 @default.
• W2077417004 hasConcept C2776755627 @default.
• W2077417004 hasConcept C2777767877 @default.
• W2077417004 hasConcept C2778041864 @default.
• W2077417004 hasConcept C2778729363 @default.
• W2077417004 hasConcept C2779117419 @default.
• W2077417004 hasConcept C2779263901 @default.
• W2077417004 hasConcept C2780007613 @default.
• W2077417004 hasConcept C2781413609 @default.
• W2077417004 hasConcept C2911091166 @default.
• W2077417004 hasConcept C33923547 @default.
• W2077417004 hasConcept C71924100 @default.
• W2077417004 hasConcept C90924648 @default.
• W2077417004 hasConceptScore W2077417004C126322002 @default.
• W2077417004 hasConceptScore W2077417004C136119220 @default.
• W2077417004 hasConceptScore W2077417004C141071460 @default.
• W2077417004 hasConceptScore W2077417004C143998085 @default.
• W2077417004 hasConceptScore W2077417004C202444582 @default.
• W2077417004 hasConceptScore W2077417004C2776694085 @default.
• W2077417004 hasConceptScore W2077417004C2776730729 @default.
• W2077417004 hasConceptScore W2077417004C2776755627 @default.
• W2077417004 hasConceptScore W2077417004C2777767877 @default.
• W2077417004 hasConceptScore W2077417004C2778041864 @default.
• W2077417004 hasConceptScore W2077417004C2778729363 @default.

• next